CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 160 enrolled
Drug / intervention
Syntocinon (Oxytocin) nasal spray +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01594775
NCT01594775Phase 1Completed

Oxytocin, Couple Interaction and Wound Healing

University of Zurich·interventional·Posted May 9, 2012·Updated Feb 25, 2014

In Brief

A Phase 1 clinical trial evaluating Syntocinon (Oxytocin) nasal spray and Placebo for Healthy Volunteers. Completed, enrolled 160 participants across 1 site.

Detailed Summary

effects of intranasal oxytocin and couple interaction on wound healing. * Trial with medicinal product

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 9, 2012
Enrollment StartOct 1, 2011
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 14.1 years ago

Interventions

Syntocinon (Oxytocin) nasal spraydrug

two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.

Placebodrug

two-times daily self-administration of nasal spray containing placebo during five days after wounding.